Tag

#MORPHOSYS

Home » MORPHOSYS

3 posts

Morphosys CFO says tafasitamab drug sales potential above $1 billion: magazine

Published 4y ago

FRANKFURT (Reuters) – German biotech company Morphosys’ tafasitamab, the group’s most advanced drug which is currently being tested, has sales potential of significantly more than $1 billion a year, its finance chief said in remarks to a magazine. “Analysts es... More »

Morphosys sees revenue boost from Janssen psoriasis drug

Published 7y ago

German biotech group Morphosys expects to receive royalties from psoriasis drug guselkumab for five months this year, its Chief Executive Simon Moroney said, after its licensee received U.S. regulatory approval. More »

Morphosys moves closer to getting first antibody drug on market

Published 8y ago

German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab. More »

We use cookies!

By using this site you agree to the use of cookies, more info.